EP Patent

EP0534363B1 — Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace

Assigned to Aventis Pharmaceuticals Inc · Expires 1997-07-09 · 29y expired

What this patent protects

The present invention relates to novel 2-substituted indane-2-mercaptoacetylaminde derivatives which are useful as inhibitors of enkephalinase and ACE.

USPTO Abstract

The present invention relates to novel 2-substituted indane-2-mercaptoacetylaminde derivatives which are useful as inhibitors of enkephalinase and ACE.

Drugs covered by this patent

Patent Metadata

Patent number
EP0534363B1
Jurisdiction
EP
Classification
—
Expires
1997-07-09
Drug substance claim
No
Drug product claim
No
Assignee
Aventis Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.